tirzepatide risk of cancer When is Mounjaro (tirzepatide) not indicated for use in patients with a history pancreatitis, thyroid cancer, or multiple endocrine neoplasia syndrome type 2? Mounjaro and Pancreatic Cancer: Evidence

Why are vivid dreams an issue for Mounjaro users

BPC-157 is a synthetic peptide compound supplied by PRIME STATE strictly for research and educational purposes

Intriguingly, GOS upregulated IL-10 more effectively than Citalopram, a selective serotonin reuptake inhibitor (Miranda et al., 2025) highlighting its therapeutic promise via the MGBA pathway

Note: prices are confirmed at consultation and can change

The group also noted that all OMMs demonstrated a generally favorable safety profile. The only one linked to any sort of increase in the risk of a serious adverse event was naltrexone/bupropion

The study showed that BPC-157 significantly promoted fibroblast outgrowth and migration, even under oxidative stress conditions